|
Heart Medicine Gene (ScienCentral)
Genetics researchers have debunked a racial myth about who might benefit from a widely used heart failure medication. As this ScienCentral video reports, the finding will eventually allow personalized treatments for this devastating disease.
(Jun 30, 2008)
New electrostatic-based DNA microarray technique could revolutionize medical diagnostics (PhysOrg)
The dream of personalized medicine — in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile — may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics.
(Jun 30, 2008)
Non-Hodgkin's Lymphoma (New York Times)
In-Depth From A.D.A.M. Diagnosis The doctor will first ask questions about the patient's medical history and perform a physical examination to detect any node enlargements.
(Jun 30, 2008)
Invitrogen and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to ... (Business Wire via Yahoo! Finance)
CARLSBAD, Calif. & MONTREAL----A scientific collaboration aimed at advancing pharmacogenomics research through the development of novel methodologies and advanced reagents for targeted medical resequencing was announced today by Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, and the Génome Québec and Montreal Heart Institute ...
(Jun 30, 2008)
Invitrogen and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to ... (wallstreet:online AG)
A scientific collaboration aimed at advancing pharmacogenomics research through the development of
(Jun 30, 2008)
Invitrogen and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to ... (Centre Daily Times)
A scientific collaboration aimed at advancing pharmacogenomics research through the development of novel methodologies and advanced reagents for targeted medical resequencing was announced today by Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and the Genome Quebec and Montreal Heart Institute Pharmacogenomics ...
(Jun 30, 2008)
Outsourcing Is Ailing Pharma's $5 Billion Remedy to Costly Drug Discovery Process (Marketwire via Yahoo! Finance)
Enhancing the productivity of the drug discovery process, while also reducing costs, is imperative if the pharmaceutical industry is to resolve the dilemma of rising R&D expenses and slowing pipelines.
(Jun 30, 2008)
Migraine mutations reveal clues to biological basis of disorder (EurekAlert!)
Fifteen percent to 20 percent of people worldwide suffer from migraines – excruciating headaches often presaged by dramatic sensations, or "auras."
(Jun 30, 2008)
Researchers are first to simulate the binding of molecules to a protein (PhysOrg)
You may not know what it is, but you burn more than your body weight of it every day. Adenosine triphosphate (ATP), a tiny molecule that packs a powerful punch, is the primary energy source for most of your cellular functions.
(Jun 30, 2008)
New Supercomputer at UCR Greatly Speeds Up Research in Computational Biology (UC Riverside)
Print Quality Image: Right click image and select "Save Target As." Thomas Girke, the director of UC Riverside's Bioinformatics Facility, stands next to Biocluster, a new supercomputer the campus has acquired. Photo credit: UCR Strategic Communications.
(Jun 30, 2008)
Migraine Mutations Reveal Clues to Biological Basis of Disorder (Newswise)
Fifteen percent to 20 percent of people worldwide suffer from migraines - excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder.
(Jun 30, 2008)
|
